Co-Amoxi-Mepha 625 Dispersible
Co-Amoxi-Mepha 625 Dispersible is a medicine authorised by Swissmedic under authorisation number 57338. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 01 February 2007 and the authorisation is valid without a time limit. ATC code J01CR02 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 57338 |
|---|---|
| Name | Co-Amoxi-Mepha 625 Dispersible |
| Full name | Co-Amoxi-Mepha 625 Dispersible, dispergierbare Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01CR02 |
| First authorisation | 01 February 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Co-Amoxi-Mepha 625 Dispersible, dispergierbare Tabletten | A | 01 February 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 10 | Tablette(n) | J01CR02 | 08.01.93 | A |
| 4 | 20 | Tablette(n) | J01CR02 | 08.01.93 | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Co-Amoxi-Mepha 625 Dispersible authorised in Switzerland?
Yes. Co-Amoxi-Mepha 625 Dispersible is authorised by Swissmedic under authorisation number 57338, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Co-Amoxi-Mepha 625 Dispersible have?
Co-Amoxi-Mepha 625 Dispersible is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Co-Amoxi-Mepha 625 Dispersible?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.